Matteo Loverro

ESGO Gyn Oncologist at Fondazione Policlinico Universitario A. Gemelli, IRCCS @unicatt.

[Matteo Loverro @MatteoLoverro]

So proud to have joined the @IJGConline Conversations with such an amazing mentor! @IJGCfellows @annafagottimd @HsuMd @pedroramirezMD

[IJGC @IJGConline]

In this #IJGCconevrsations epidose, @pedroramirezMD discusses about real-word #PARPi maintenance and recurrence patterns with @MatteoLoverro and @annafagottimd @Unicatt

Tune in now 🎧 https://t.co/jYGPv0LqV5

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen

[IJGC @IJGConline]

Happy Holidays from the #IJGCfamily 🎄✨

Cheers🥂 to a bright year ahead for our global community!

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul @HousseinELHAJJ3 @EokoyeMD @AinhoaMada @giovanni_aletti @radoncology @RParejaGineOnco

[IJGC @IJGConline]

The HER2 Challenge in #GynCancers: Testing, Treatment, and the Need for Standards.

🎄 https://t.co/a9UVZ6NRil

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[Matteo Loverro @MatteoLoverro]

What a family!! 😍

[IJGC @IJGConline]

And that's a wrap!!!
The last #IJGCClub of the year, with an incredible guest. 🔥

Thank you, Luis @lchiv4 for such a wonderful and insightful discussion. We had 82 attendees, one of our largest attendances for journal clubs! 🤩

Thanks to @IGCSociety and @ESGO_society for all the support, and to the best fellows for your wonderful questions.

You can find the recording here 👉 https://t.co/ZJbBOmW3MF

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[IJGC @IJGConline]

Ultrasound-Guided vs. Per-Vagina Biopsy: Which yields better results for recurrent or persistente #cervicalcancer?

🔎 https://t.co/KO8blREaAv

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[IJGC @IJGConline]

#WinterPodcast ❄️
We’re bringing back our most-played episodes—starting with the ESGO/INCIP 2025 Cancer in Pregnancy Guidelines featuring Frédéric Amant

🎧 https://t.co/HMEYu0kie0

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[IJGC @IJGConline]

The big debate in #ovariancancer continues🔥 🔥

🎙️ Tune into our new #IJGCconversations episode with Dr. Luis Chiva @lchiv4 discussing the #SUROVAstudy

🎧 https://t.co/2HEenVBncf

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[Matteo Loverro @MatteoLoverro]

@Cucinella_G @IJGConline @IGCSociety 😍

[Matteo Loverro @MatteoLoverro]

Can’t miss this!! Join us tomorrow!! @IJGConline @IJGCfellows

[ESGO @ESGO_society]

ℹ️ Join ENYGO next week for a Surgical Mentorship webinar on pelvic exenteration & reconstruction!

This series of webinars enables young surgeons to share their accomplishments and discuss them with leading experts. 🙌

On October 30, we welcome:

Experts
🔸Gwenael Ferron
🔸Vito Chiantera
🔸Nicolo Bizzarri

Presenters
🔸Matteo Loverro
🔸Giuseppe Cucinella
🔸Martina Angeles

Moderators
🔸Louisa Proppe
🔸Enrique Chacon

[Nicolò Bizzarri @NicoloBizzarri]

Super @ESGEorg Congress in Istanbul! Congratulations to the organizing cmt and thanks for inviting me as speaker🤩! @ESGO_society @ENYGO_officia

[IJGC @IJGConline]

A fun and highly interactive #IJGCclub today with Mario Leitao @leitaomd and Giuseppe Cucinella @Cucinella_G!🔥 🔥

Thanks to all who joined, asked questions, and made this session so dynamic.
We can’t wait to see you at the next one! 💬✨

Special thank to @ESGO_society @IGCSociety 🫶

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[Matteo Loverro @MatteoLoverro]

Join us for an outstanding #JournalClub with @Cucinella_G and @leitaomd discussing the best evidences we’ll see for years on this rare condition.
@IJGConline @IJGCfellows

[IJGC @IJGConline]

Join us #IJGCclub
📆16/10/2025
⏰11am CDT/6pm CET

Mark your calendars 📅 for an exciting #IJGCclub 💥
Endometrial carcinosarcoma without myoinvasion with Giuseppe Cucinella @Cucinella_G and Mario Leitao @leitaomd

💻 https://t.co/U879Rhb83X

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[IJGC @IJGConline]

🎙️ New #IJGCConversations!
@pedroramirezMD speaks with Dr. Alexander B. Olawaiye 🇺🇸 about the #ROSELLA Trial exploring #Relacorilant in Platinum Resistant #OvarianCancer 💊🎗️

🎧 Listen now 🌍
🔗 https://t.co/oUPzxOhM5F

@HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

#WeeklyPodcast #IJGConline #Research #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

[IJGC @IJGConline]

📺 Did you miss the last #IJGCclub?

Catch up now on our YouTube channel! 🎥
This session covers the ESGO/INCIP guidelines on managing patients with #gynecologicalcancers during pregnancy🤰💜

🔗 Watch here: https://t.co/IfumK7YZqY

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[IJGC @IJGConline]

📢 Applications are now open for the IJGC #EditorialFellowshipProgram!

A unique opportunity to gain hands-on editorial experience and contribute to advancing #gynecologiconcology research.

🗓️ Apply now: https://t.co/6unRs3hS3Q

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul @RParejaGineOnco

[Nicolò Bizzarri @NicoloBizzarri]

Consultations with gynecologic oncologists are important to learn about screening and prevention of gynecologic cancers! @ESGO_society @IJGConline @IGCSociety @WorldGOday @ENYGO_official @IJGCfellows

[IJGC @IJGConline]

#EditorialFellows
We are pleased to welcome Matteo Loverro @MatteoLoverro, #GynOnc at the Fondazione Policlinico Universitario A. Gemelli, in Rome 🇮🇹

✨ Welcome, Matteo! We’re really looking forward to working with you.

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @CSabiniMD @ZaniruRaul

[Matteo Loverro @MatteoLoverro]

A truly thought-provoking review, inspiring reflections on gaps in preoperative diagnosis and surgical management, and even more on future medical therapies.
Amazing paper @GiorgioBogani @gcarusomd @leitaomd

[IJGC @IJGConline]

#EditorsChoice #UterineLeiomyosarcoma is rare, aggressive, and hard to diagnose. Multidisciplinary care is key.

👉 Learn more in the latest review: https://t.co/X0dIc9HHNn

@gcarusomd @BoganiGiorgio @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

[Matteo Loverro @MatteoLoverro]

MIS works even in non-epithelial OC recurrences… and this impressive series on granulosa cell tumor recurrence is just outstanding. Absolutely unmissable! 🚀🎙️

[IJGC @IJGConline]

🎙️ New #IJGCconversations!
@pedroramirezMD talks with Tyler Hillman & Allison Lynn Brodsky about surgical approach in recurrent granulosa cell tumor.

🎧 Don’t miss this insightful discussion 👉 https://t.co/txjRD5lhSs

@HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul

#WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

[Zaniru Raúl @ZaniruRaul]

🦠 HPV is one of the most common infections worldwide. Evidence shows that vaccination and screening are the most effective tools to prevent disease and reduce stigma. #GOAgainstStigma
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @MathildeDel2 @DrPervan @T_Meschini @moe_byrneMD @MatteoLoverro @CSabiniMD @ZaniruRaul @WorldGOday